DelveInsight has launched a new report on “Mesothelioma – Market Insights, Epidemiology, and Market Forecast-2032”.
Some of the key facts of the Mesothelioma Market Report:
In EU-5 countries, the highest number of incident cases of Mesothelioma was found in the United Kingdom with 2,804 cases in 2017, followed by Germany and Italy.
The total Incident cases of Mesothelioma in the 7MM were observed to be 13,028 cases in 2017 which are estimated to decline during the study period (2019-2032).
Spain accounted for the least number of incident cases, i.e., 524 cases in 2017.
The United States accounted for nearly 3,200 mesothelioma cases for the year 2017.
Key benefits of the report:
Mesothelioma market report covers a descriptive overview and comprehensive insight of the Mesothelioma Epidemiology and Mesothelioma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Mesothelioma market report provides insights on the current and emerging therapies.
Mesothelioma market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Mesothelioma market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Mesothelioma market.
Mesothelioma is a rare, aggressive form of malignant tumor that is caused by inhaled asbestos fibers and forms in the lining of the lungs, abdomen, or heart. There are four primary types of mesothelioma based on tumor location: Pleural Mesothelioma (MPM), Peritoneal Mesothelioma, Pericardial Mesothelioma, and Testicular Mesothelioma. Pleural mesothelioma is a cancer of the pleura, which is the mesothelium surrounding the lungs and it is the most common type of mesothelioma, accounting for 80 – 90% of all diagnosed cases. Because males are exposed to asbestos more often, they are more likely to be diagnosed with mesothelioma.
The dynamics of the Mesothelioma market are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Trizell Ltd, AstraZeneca, Momotaro-Gene, TCR2 Therapeutics, Roche, and others during the forecasted period 20197-2032.
Learn more by requesting for sample @ Mesothelioma Market Landscape.
Mesothelioma Pipeline Therapies and Key Companies
TC-210 T-Cells: TCR2 Therapeutics
Tecentriq Plus Avastin: Roche
Mesothelioma Market Drivers
Rapidly Evolving Landscape of New Therapeutic Opportunities
Developments in Diagnosis and Staging
Rich Emerging Pipeline
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Mesothelioma Patient Share (%) Overview at a Glance
5. Mesothelioma Market Overview at a Glance
6. Mesothelioma Disease Background and Overview
7. Mesothelioma Epidemiology and Patient Population
8. Country-Specific Patient Population of Mesothelioma
9. Mesothelioma Current Treatment and Medical Practices
10. Unmet Needs
11. Mesothelioma Emerging Therapies
12. Mesothelioma Market Outlook
13. Country-Wise Mesothelioma Market Analysis (2019-2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Mesothelioma Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Click here to read more about Mesothelioma Market Outlook 2032.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States